Abstract
Objectives
The fatty acids docosahexaenoic (DHA) and arachidonic (AA) acids are in breast milk are important for the infant's development. Our objective was to use data collected in the Alberta Pregnancy Outcomes and Nutrition (APrON) cohort, to identify the relationship between maternal serum status of DHA and the concentration of DHA in breast milk and infants’ plasma phospholipids (PL) at three months postpartum.
Methods
The study used data from the APrON cohort. The cohort participants were 31.1 ± 4.5 years and the majority had a healthy BMI (24.2 ± 4.8 kg/m,2) and high education status (88% trade, university or higher). Maternal and infant blood samples and breast milk spot samples were collected and the fatty acid composition/concentration of DHA and AA determined by gas liquid chromatography.
Results
The median DHA concentrations (µg/mL) in maternal serum phospholipids (PL) significantly changed through gestation (P < 0.05) and was 43 (IQR 28–59, n = 287), 58 (IQR 38–80, n = 1115), 83 (IQR 65–103, n = 794) and 10 (IQR 7–14, n = 891) for each trimester and 3 months postpartum, respectively. Compared to trimester 1, DHA concentration was the higher in the third trimester and lowest during breastfeeding (P < 0.001). The %DHA in breast milk (median: 0.19%, IQR: 0.13–0.29%, n = 1483) was lower than the reported global average, while AA (median: 0.47%, IQR: 0.36–0.55%, n = 1483) was similar. Postpartum breast milk DHA directly correlated with maternal (r = 0.38, P < 0.001) and infant serum PL DHA concentrations (P < 0.05).
Conclusions
In summary, maternal PL DHA concentration changed significantly through gestation and DHA concentration in breast milk at three months postpartum was below the proportion considered optimal (0.30–0.64%). Targeting maternal DHA status will help optimize the concentration of this essential long chain polyunsaturated fatty acid in breast milk and ultimately improve infant status.
Funding Sources
CIHR and Alberta Innovates.